The prognostic biomarker TPGS2 is correlated with immune infiltrates in pan-cancer: a bioinformatics analysis
CONCLUSIONS: TPGS2 is aberrantly expressed in most cancer tissues and might be associated with immune cell infiltration in the tumor microenvironment. TPGS2 could serve not only as a biomarker for predicting clinical outcomes, but also as a promising biomarker for evaluating and developing new approaches to immunotherapy in many types of cancers, especially colon adenocarcinoma and stomach adenocarcinoma.PMID:38617524 | PMC:PMC11009813 | DOI:10.21037/tcr-23-113
Source: Cell Research - Category: Cytology Authors: Zujun Ding Qing Ding Hang Li Source Type: research
More News: Adenocarcinoma | Adrenocortical Carcinoma | Brain | Cancer | Cancer & Oncology | Carcinoma | Colon Cancer | Colorectal Cancer | Cytology | Gastric (Stomach) Cancer | Genetics | Hepatocellular Carcinoma | Immunotherapy | Liver | Liver Cancer | Neurology | Urology & Nephrology